A citation-based method for searching scientific literature


List of co-cited articles
41 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long).
Bernard Zinman, Athena Philis-Tsimikas, Bertrand Cariou, Yehuda Handelsman, Helena W Rodbard, Thue Johansen, Lars Endahl, Chantal Mathieu. Diabetes Care 2012
225
20

Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael A Ihnat, Jessica E Thorpe, Roberto Testa, Massimo Boemi, Dario Giugliano. Diabetes 2008
723
20

Mean amplitude of glycemic excursions, a measure of diabetic instability.
F J Service, G D Molnar, J W Rosevear, E Ackerman, L C Gatewood, W F Taylor. Diabetes 1970
835
20

Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial.
Pablo Aschner, Juliana Chan, David R Owens, Sylvie Picard, Edward Wang, Marie-Paule Dain, Valérie Pilorget, Akram Echtay, Vivian Fonseca. Lancet 2012
88
13

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.
Alexandra E Butler, Juliette Janson, Susan Bonner-Weir, Robert Ritzel, Robert A Rizza, Peter C Butler. Diabetes 2003
13

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
William C Knowler, Elizabeth Barrett-Connor, Sarah E Fowler, Richard F Hamman, John M Lachin, Elizabeth A Walker, David M Nathan. N Engl J Med 2002
13


Type 2 diabetes: principles of pathogenesis and therapy.
Michael Stumvoll, Barry J Goldstein, Timon W van Haeften. Lancet 2005
13


A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet.
Julio C Fraulob, Rebeca Ogg-Diamantino, Caroline Fernandes-Santos, Marcia Barbosa Aguila, Carlos A Mandarim-de-Lacerda. J Clin Biochem Nutr 2010
232
13

Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity.
Yiling Si, Yali Zhao, Haojie Hao, Jiejie Liu, Yelei Guo, Yiming Mu, Jing Shen, Yu Cheng, Xiaobing Fu, Weidong Han. Diabetes 2012
154
13

Mobilization of bone marrow-derived progenitors.
J-P Lévesque, I G Winkler, S R Larsen, J E J Rasko. Handb Exp Pharmacol 2007
41
13

Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines.
Telford Y Yeung, Karen L Seeberger, Tatsuya Kin, Adetola Adesida, Nadr Jomha, A M James Shapiro, Gregory S Korbutt. PLoS One 2012
84
13



Thiazolidinediones.
Hannele Yki-Järvinen. N Engl J Med 2004
13

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
13

Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health.
James H O'Keefe, Neil M Gheewala, Joan O O'Keefe. J Am Coll Cardiol 2008
280
13


Postprandial hyperglycemia as an etiological factor in vascular failure.
Koichi Node, Teruo Inoue. Cardiovasc Diabetol 2009
96
13

Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes.
Olubukola Ajala, Patrick English, Jonathan Pinkney. Am J Clin Nutr 2013
364
13





A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulin.
Hiroshi Nomoto, Hideaki Miyoshi, Hajime Sugawara, Kota Ono, Shingo Yanagiya, Mayuko Oita, Akinobu Nakamura, Tatsuya Atsumi. Diabetol Metab Syndr 2017
23
13

Glucose variability; does it matter?
Sarah E Siegelaar, Frits Holleman, Joost B L Hoekstra, J Hans DeVries. Endocr Rev 2010
276
13


Glycemic Variability: How Do We Measure It and Why Is It Important?
Sunghwan Suh, Jae Hyeon Kim. Diabetes Metab J 2015
155
13

Variability in metabolic parameters and risk of dementia: a nationwide population-based study.
Seung-Hwan Lee, Kyungdo Han, Hanna Cho, Yong-Moon Park, Hyuk-Sang Kwon, Gunseog Kang, Kun-Ho Yoon, Mee Kyoung Kim. Alzheimers Res Ther 2018
28
13

Variability of body weight and health outcomes in the Framingham population.
L Lissner, P M Odell, R B D'Agostino, J Stokes, B E Kreger, A J Belanger, K D Brownell. N Engl J Med 1991
482
13

Impact of Visit-to-Visit Variability in Systolic Blood Pressure on Cardiovascular Outcomes in Korean National Health Insurance Service-National Sample Cohort.
SeongIl Choi, Jinho Shin, Sung Yong Choi, Ki Chul Sung, Sang Hyun Ihm, Kwang-Il Kim, Yu-Mi Kim. Am J Hypertens 2017
9
22

Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study.
Mee Kyoung Kim, Kyungdo Han, Hun-Sung Kim, Yong-Moon Park, Hyuk-Sang Kwon, Kun-Ho Yoon, Seung-Hwan Lee. Eur Heart J 2017
100
13

Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population.
Mee Kyoung Kim, Kyungdo Han, Yong-Moon Park, Hyuk-Sang Kwon, Gunseog Kang, Kun-Ho Yoon, Seung-Hwan Lee. Circulation 2018
84
13


Glycemic variability in the development of cardiovascular complications in diabetes.
Annunziata Nusca, Dario Tuccinardi, Marzia Albano, Camilla Cavallaro, Elisabetta Ricottini, Silvia Manfrini, Paolo Pozzilli, Germano Di Sciascio. Diabetes Metab Res Rev 2018
56
13

Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial.
Sripal Bangalore, Andrei Breazna, David A DeMicco, Chuan-Chuan Wun, Franz H Messerli. J Am Coll Cardiol 2015
104
13

Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease.
Elvira O Gosmanova, Margit K Mikkelsen, Miklos Z Molnar, Jun L Lu, Lenar T Yessayan, Kamyar Kalantar-Zadeh, Csaba P Kovesdy. J Am Coll Cardiol 2016
145
13

Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial.
Yoichiro Hirakawa, Hisatomi Arima, Sophia Zoungas, Toshiharu Ninomiya, Mark Cooper, Pavel Hamet, Giuseppe Mancia, Neil Poulter, Stephen Harrap, Mark Woodward,[...]. Diabetes Care 2014
185
13

Metformin and digestive disorders.
M Bouchoucha, B Uzzan, R Cohen. Diabetes Metab 2011
79
6

Efficacy and safety of sitagliptin versus glipizide in patients with type 2 diabetes and moderate-to-severe chronic renal insufficiency.
Juan Camilo Arjona Ferreira, Michel Marre, Nir Barzilai, Hua Guo, Gregory T Golm, Christine McCrary Sisk, Keith D Kaufman, Barry J Goldstein. Diabetes Care 2013
116
6

Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Nir Barzilai, Hua Guo, Erin M Mahoney, Suzanne Caporossi, Gregory T Golm, Ronald B Langdon, Debora Williams-Herman, Keith D Kaufman, John M Amatruda, Barry J Goldstein,[...]. Curr Med Res Opin 2011
101
6


Effect of gastric bypass surgery on the absorption and bioavailability of metformin.
Raj S Padwal, Raniah Q Gabr, Arya M Sharma, Lee-Ann Langkaas, Dan W Birch, Shahzeer Karmali, Dion R Brocks. Diabetes Care 2011
60
6

Assessing the quality of reports of randomized clinical trials: is blinding necessary?
A R Jadad, R A Moore, D Carroll, C Jenkinson, D J Reynolds, D J Gavaghan, H J McQuay. Control Clin Trials 1996
6

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Int J Surg 2010
6

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial.
Richard M Bergenstal, Carol Wysham, Leigh Macconell, Jaret Malloy, Brandon Walsh, Ping Yan, Ken Wilhelm, Jim Malone, Lisa E Porter. Lancet 2010
441
6

Into the future: prevention of diabetes.
Yolanda E Bogaert, Robert W Schrier. Contrib Nephrol 2011
5
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.